About
Our Name
Mission
Values
Leadership
Board of Directors
Science
Therapeutic Focus
Pipeline
Palmoplantar pustulosis (PPP)
Familial Mediterranean fever (FMF)
Behcet’s disease
Hidradenitis suppurativa (HS)
Scientific Publications
Clinical Trials
For Patients
Investors
Partnerships
Newsroom
Press Releases
In the News
Events
Contact
About
Our Name
Mission
Values
Leadership
Board of Directors
Science
Therapeutic Focus
Pipeline
Palmoplantar pustulosis (PPP)
Familial Mediterranean fever (FMF)
Behcet’s disease
Hidradenitis suppurativa (HS)
Scientific Publications
Clinical Trials
For Patients
Investors
Partnerships
Newsroom
Press Releases
In the News
Events
Contact
IN THE NEWS
Scrip Asks…What Does 2023 Hold For Biopharma? Part 1: The Funding Environment
January 4, 2023
Original Article Link
2022 © Copyright. Aristea Therapeutics. All Rights Reserved.